** Customer Service Lines: For Enquiries call 0700-1-NAFDAC (0700-1-623322), For Complaints call 0800-1-NAFDAC (0800-1-623322) ** Customer Service Lines: For Enquiries call 0700-1-NAFDAC (0700-1-623322), For Complaints call 0800-1-NAFDAC (0800-1-623322) ** Customer Service Lines: For Enquiries call 0700-1-NAFDAC (0700-1-623322), For Complaints call 0800-1-NAFDAC (0800-1-623322)
** Customer Service Lines: For Enquiries call 0700-1-NAFDAC (0700-1-623322), For Complaints call 0800-1-NAFDAC (0800-1-623322) ** Customer Service Lines: For Enquiries call 0700-1-NAFDAC (0700-1-623322), For Complaints call 0800-1-NAFDAC (0800-1-623322) ** Customer Service Lines: For Enquiries call 0700-1-NAFDAC (0700-1-623322), For Complaints call 0800-1-NAFDAC (0800-1-623322)

NAFDAC Refutes Claims of Approving Herbal Tea Promoting Smoking

The attention of the National Agency for Food and Drug Administration and Control (NAFDAC) has been drawn to a misleading video circulating on social media, falsely alleging that the Agency approved the registration of a herbal product claiming that “smoking is healthy” when used with their product. NAFDAC categorically refutes this claim as false, baseless, […]

List of Withdrawn, Suspended and Cancelled products as approved by NAFDAC

  This is to inform the General Public that the following products are approved for withdrawal, suspension and cancellation by NAFDAC. They are therefore no longer permitted for manufacture, importation, exportation, distribution, advertisement, sale and use within Nigeria. Please note that: 1. The Certificate of Registration of a product is said to be withdrawn when […]

Implementation of ICH Q1 and Q7 Guidelines

NAFDAC WORKSHOP ON ICH Q1 AND Q7 GUIDELINES AND ITS IMPLEMENTATION The National Agency for Food and Drug Administration and Control (NAFDAC), in partnership with Northeastern University, USA, and the International Council for Harmonization (ICH), successfully organized a workshop on ICH Q1 Stability Guidelines and ICH Q7 Good Manufacturing Practice (GMP) for Active Pharmaceutical Ingredients […]

Emergency use authorization of the Mpox vaccine by NAFDAC: A crucial step in Nigeria’s public health response

The 2022 Monkeypox (Mpox) outbreak, initially detected in the United Kingdom, posed a significant global health challenge. The World Health Organization’s declaration of a Public Health Emergency of International Concern underscored the urgency of the situation. In Nigeria, the National Agency for Food and Drug Administration and Control (NAFDAC) took proactive measures to ensure the […]

Unlocking the healthcare value chain: 2nd regional workshop on manufacturing Active Pharmaceutical Ingredients and excipients in Nigeria

Introduction Active Pharmaceutical Ingredients (APIs) are the essential components of pharmaceutical products responsible for the intended therapeutic effect.They form the backbone of pharmaceutical formulation and their quality directly impacts the safety and efficacy of the medicines which directly impacts public health. The National Agency for Food and Drug Administration and control (NAFDAC) has recognised the […]